Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
- Unpacking The EU's Mutual Recognition Agreements For Pharma
- The Module Type Package Wants All Your Equipment To Start Talking
- Why Your MVP And Its Evolution Matters To Manufacturing
- TFF Offers Ideal Anaerobic, GMP Conditions For LBP Concentration
- Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up
- Strained Manufacturing, Complexity Stymie In Vivo Progress
- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
EDITOR'S DESK
-
The 9 Fastest-Growing Outsourcing Segments
Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.
At BioProcess International 2025, leaders from AbbVie and Amgen gave keynote presentations about how their companies are advancing product development through digital tools.
AI consultant Kat Kozyrytska advocates for ethical AI adoption and explains its potential to foster collaboration across the industry.
Takeda head of process development, Amy Shaw, explains what factors to consider when scaling up or scaling out cell therapy manufacturing.
DeciBio partner Carl Schoellhammer, Ph.D., speaks on the record with Bioprocess Online's chief editor Tyler Menichiello at the 2025 BioProcess International conference in Boston.
GUEST COLUMNISTS
-
Unpacking The EU's Mutual Recognition Agreements For Pharma
MRAs can save resources for regulators and drug makers by, among other things, reducing the number of inspections and waiving retesting requirements.
-
The Module Type Package Wants All Your Equipment To Start Talking
A forthcoming ISPE guide uses case studies to aid in the design of plug-and-play process skids with implications for every step in the manufacturing process continuum.
-
Four Reasons You Should Choose Lyophilization for Your Next Project
Lyophilization ensures product stability, extends shelf life, supports sensitive formulations, and simplifies storage and transport, making it a critical choice for modern drug development projects.
-
Why Your MVP And Its Evolution Matters To Manufacturing
Minimum viable product is one of the most important inputs to developing a manufacturing process. It defines essentials that matter to the people who make the product.
-
TFF Offers Ideal Anaerobic, GMP Conditions For LBP Concentration
When configured correctly, TFF provides the gentle processing environment and oxygen protection required for strict anaerobes.
-
Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up
Computational success is no stand-in for therapeutic readiness. Innovators must learn to discern between models rooted in science and those that speculate.
-
Strained Manufacturing, Complexity Stymie In Vivo Progress
Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.
-
To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
The choice of delivery dictates the complexity of manufacturing, which in turn determines the eventual cost and accessibility of the therapy.
BIOPROCESSING WHITE PAPERS
-
The Evolution Of EAM/CMMS In Pharma Manufacturing
Explore pharma’s shift from paper-based maintenance to modern EAM/CMMS that shows how digital tools boost compliance, reduce downtime, and improve data accuracy and productivity.
-
The Impact Of Artificial Intelligence On CQV7/23/2025
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Establishing Commercial Manufacturing Services For ADCs6/3/2024
Explore how one organization built upon 15+ years of experience and an extensive knowledge base of biologics manufacturing to establish commercial-scale ADC manufacturing capabilities.
-
Three Steps To Digital Transformation In Life Sciences Manufacturing1/30/2025
Explore trends that are transforming the industry, some common speedbumps on the road to innovation, and how a new platform offers unprecedented process transparency and continuous improvement.
-
Factors To Consider While Selecting Stoppers For Lyophilized Vials10/16/2024
Ensure the success and stability of your lyophilized products by choosing the right container-closure system — explore your stopper options, here.
-
Simplifying The Transition To Multi-Column Chromatography4/5/2024
Explore the advantages of multi-column chromatography and how to transfer your process from batch to an intensified system, step-by-step.
BIOPROCESSING APP NOTES & CASE STUDIES
- Simplified Workflow Using Automated Instrument Setup And Compensation On The BD FACSLyric™ Flow Cytometer
- Bypassing The Challenges Of Paper-Based Validation
- Advancing Cell Therapy Manufacturing: Rapid Sterility Testing
- Enabling Accelerated Raman Model Calibration For Real-Time Monitoring
- Analyzing Biological Drug Effects In 3D
- FDA Releases Draft Guidance To Accelerate Biosimilar Development
- Supporting The Next Generation Of ADCs
- AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing
- On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
- On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing
- On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.
- Single-Use Standardization Starts At Home
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles digs into the industry’s growing focus on knowledge management as an indispensable facet of biomanufacturing and pharmaceutical development, exploring how it plays into risk management, quality, vendor relationships, and supply chain resilience.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 12.15.25 -- 4 Key Challenges Slowing Advanced Therapy Progress—And How to Overcome Them
- 12.15.25 -- TFF Offers Ideal Anaerobic, GMP Conditions For LBP Concentration
- 12.13.25 -- Bioprocess Online Best Of November
- 12.12.25 -- New Podcast Episodes: Building An Oral Vaccine Platform, Biotech Collaboration Strategy, Treating Inherited Retinal Disorders
- 12.12.25 -- STREAM Edition: Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.